Literature DB >> 9972102

Geographic heterogeneity of 4 common worldwide cystic fibrosis non-DF508 mutations in Brazil.

S Raskin1, J A Phillips, G Kaplan, M McClure, C Vnencak-Jones, T Rozov, J M Cardieri, P Marostica, F Abreu, R Giugliani, F Reis, N A Rosario, N Ludwig, L Pereira, F Faucz, J Gabardo, L Culpi.   

Abstract

Cystic fibrosis (CF) is an autosomal recessive disease caused by at least 750 different mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The frequency of the most common mutation (DF508) in Brazilian patients of European origin is 47%. To determine the frequency of 4 other common CF mutations (G542X, G551D, R553X, and N1303K) in Brazilian patients of European origin, we used direct polymerase chain reaction (PCR) amplification of DNA obtained from dried blood spots on Guthrie cards. The DNA came from 247 non-DF508 chromosomes from 172 Brazilian CF patients ascertained from 5 different states of Brazil. The results show that the 4 mutations account for 17% of the non-DF508 alleles and only 9% of the total number of Brazilian CF alleles. Overall, the frequency of each mutation is different from northern European and North American populations but similar to southern European populations, mainly the Italian and Spanish populations. When Brazilian patients of European origin are grouped according to state of birth, the frequencies of the mutations are significantly different between southern and southeastern states of Brazil. Therefore there are serious implication for risk assessment of DNA-based tests in heterogeneous populations such as Brazilians. Further studies are needed to identify the remaining 44% of CF mutations for the different populations and regions of Brazil.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9972102

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  3 in total

1.  Race and ethnicity of mothers with Spanish surnames.

Authors:  Carlos R Oliveira; Alicia Guzman; Gaynelle Hensely; Melissa H Leps; Nancy A Miller; Pablo J Sánchez
Journal:  J Public Health Epidemiol       Date:  2013-09-30

2.  Cystic fibrosis transmembrane conductance regulator mutations at a referral center for cystic fibrosis.

Authors:  Cyntia Arivabeni de Araújo Correia Coutinho; Fernando Augusto de Lima Marson; Antônio Fernando Ribeiro; José Dirceu Ribeiro; Carmen Silvia Bertuzzo
Journal:  J Bras Pneumol       Date:  2013 Sep-Oct       Impact factor: 2.624

3.  Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis.

Authors:  Vinícius Buaes Dal'Maso; Lucas Mallmann; Marina Siebert; Laura Simon; Maria Luiza Saraiva-Pereira; Paulo de Tarso Roth Dalcin
Journal:  J Bras Pneumol       Date:  2013 Mar-Apr       Impact factor: 2.624

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.